( S ) Few studies of medical therapies for endometriosis report outcomes that are relevant to patients , and many women gain only limited or intermittent benefit from treatment
OBJECTIVE To assess patient response rates to medical therapies used to treat endometriosis-associated pain .
Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis.
OBJECTIVE To evaluate the effectiveness of a levonorgestrel-releasing IUD as therapy for endometriosis of the rectovaginal septum . DESIGN Prospect i ve therapeutic non-r and omized , self-controlled clinical trial analyzing changes in pain symptoms and size of lesions induced by the levonorgestrel-releasing IUD over 12 months . SETTING Tertiary referral center for treatment of deep endometriosis . PATIENT(S ) Eleven symptomatic patients with rectovaginal endometriosis . INTERVENTION(S ) A levonorgestrel-releasing IUD was inserted and maintained for 12 months . MAIN OUTCOME MEASURE(S ) Severity of dysmenorrhea , pelvic pain , and deep dyspareunia were assessed before insertion of the IUD and throughout treatment . The size of rectovaginal endometriotic lesions were evaluated by using transrectal and transvaginal ultrasonography . RESULT ( S ) Dysmenorrhea , pelvic pain , and deep dyspareunia greatly improved and the size of the endometriotic lesions was significantly reduced by treatment . CONCLUSION ( S ) Insertion of a levonorgestrel-releasing IUD alleviates pain and reduces the size of lesions in patients with endometriosis of the rectovaginal septum
( S ) Few studies of medical therapies for endometriosis report outcomes that are relevant to patients , and many women gain only limited or intermittent benefit from treatment
OBJECTIVE To assess patient response rates to medical therapies used to treat endometriosis-associated pain .